GAMMA Investing’s BioLineRX BLRX Stock Holding History

GAMMA Investing’s Portfolio BLRX Stock Details BLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-5	Closed	-$124	–	3590
2024 Q2	$124	Sell	5 -95	-95%	-$2.55K	﹤0.01%	3400
2024 Q1	$4.47K	Buy	+100	New	+$5.02K	﹤0.01%	2458

Other funds holding BLRX

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VFA

Values First Advisors Gray, Tennessee $192M AUM 24.96% 1-Year Est. Return

PAM

PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $8.94B AUM 20.84% 1-Year Est. Return

AWS

Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

GAMMA Investing's BLRX Position: Q3 2024 in Review

GAMMA Investing sold out of BioLineRX (BLRX) in Q3 2024, closing a stake of 5 shares — an estimated $124 sold.

GAMMA Investing first reported a position in BLRX in Q1 2024 and held it in 2 quarters. The position peaked at $4.47K in Q1 2024. 31 funds tracked by Wall St. Rank hold BLRX as of Q3 2024.

GAMMA Investing reported no remaining BioLineRX position as of Q3 2024 after selling out during the quarter.
GAMMA Investing sold 5 BioLineRX shares in Q3 2024, an estimated $124.
GAMMA Investing first reported a position in BioLineRX in Q1 2024 and held it in 2 quarters.
GAMMA Investing's BioLineRX position peaked at $4.47K in Q1 2024.
31 funds tracked by Wall St. Rank held BioLineRX as of Q3 2024.

Based on GAMMA Investing's 13F filing for Q3 2024, filed 7 Oct 2024.